B
Workshop Agendas1

Raleigh Workshop

April 15, 2010

Renaissance Raleigh North Hills Hotel

Raleigh, North Carolina


Austin Workshop

April 27, 2010

AT&T Executive Education and Conference Center

Austin, Texas


Seattle Workshop

May 11, 2010

The Alexis Hotel Seattle

Seattle, Washington


Workshop Objectives

Following the recent, and ongoing, H1N1 vaccination campaigns, the objectives of this workshop are to

  • Examine innovative efforts used to distribute and administer vaccine and discuss how they may inform future efforts.

  • Examine how jurisdictions and providers interpreted and applied the CDC/ACIP recommendations for use of H1N1 vaccine.

1

To save space, the individual agendas from each regional meeting have been compiled into a single document. Under each session, speakers have been identified based on the meeting location where they participated: Raleigh, Austin, and/or Seattle.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 103
B Workshop Agendas1 Raleigh Workshop April 15, 2010 Renaissance Raleigh North Hills Hotel Raleigh, North Carolina Austin Workshop April 27, 2010 AT&T Executive Education and Conference Center Austin, Texas Seattle Workshop May 11, 2010 The Alexis Hotel Seattle Seattle, Washington Workshop Objectives Following the recent, and ongoing, H1N1 vaccination campaigns, the objectives of this workshop are to • Examine innovative efforts used to distribute and administer vaccine and discuss how they may inform future efforts. • Examine how jurisdictions and providers interpreted and applied the CDC/ACIP recommendations for use of H1N1 vaccine. 1 To save space, the individual agendas from each regional meeting have been compiled into a single document. Under each session, speakers have been identified based on the meeting location where they participated: Raleigh, Austin, and/or Seattle. 103

OCR for page 103
104 THE 2009 H1N1 INFLUENZA VACCINATION CAMPAIGN • Highlight successful approaches used by jurisdictions to develop and use innovative partnerships with traditional and non- traditional partners, such as community groups and the private sector, to enhance communication with the public and providers and to effectively distribute and administer vaccine. • Discuss strategies used to collect, monitor, evaluate, and use data during the H1N1 vaccination campaigns. • Discuss lessons learned and challenges that arose during the vaccination campaigns, and identify strategies to address these challenges for future emergency vaccination programs and other medical countermeasures dispensing campaigns. Welcoming Remarks Raleigh JEFFREY ENGEL, North Carolina Department of Health and Human Services Austin DAVID LAKEY, Texas Department of State Health Services Seattle MARY SELECKY, Washington State Department of Health Charge to Workshop Speakers and Participants Raleigh, Seattle JAY BUTLER, Workshop Co-Chair, Centers for Disease Control and Prevention Austin, Seattle JEFFREY DUCHIN, Workshop Co-Chair, Public Health–Seattle & King County, WA SESSION I: DISTRIBUTION STRATEGIES Session Objectives • Provide an overview of strategies developed to receive, store, and distribute vaccine to participating H1N1 vaccine providers and administration sites in the community and strategies developed to administer vaccine:

OCR for page 103
APPENDIX B 105 o How were providers and vaccinators recruited to participate in the H1N1 vaccination program? What partnerships were used? Did these partnerships rely on preexisting relationships and, if so, were they successful? Were new partnerships built? o What lessons were learned from the use of a centralized distribution mechanism? o Was vaccine distributed to administration sites through centralized healthcare system distribution sites or directly to administration sites? o How did the availability of specific vaccine formulations and indications impact distribution and administration strategies? • Discuss the successes, lessons learned, and how challenges might be addressed to help improve future emergency vaccination programs and other medical countermeasure campaigns. Overview and Panel Objectives Raleigh, Seattle JAY BUTLER, Panel Chair, Centers for Disease Control and Prevention Austin JEFFREY DUCHIN, Panel Chair, Public Health–Seattle & King County, WA Panel Remarks Raleigh SUSAN COOPER, Tennessee Department of Health ANNE BAILOWITZ, Baltimore City Health Department, MD JAMES TURNER, American College Health Association AMANDA FULLER, North Carolina Department of Health and Human Services GREG PRIMUTH, Walgreens KIM BOGGESS, University of North Carolina at Chapel Hill and the American College of Obstetricians and Gynecologists

OCR for page 103
106 THE 2009 H1N1 INFLUENZA VACCINATION CAMPAIGN Austin DON WILLIAMSON, Alabama Department of Public Health JOHN REDD, Indian Health Service ANN SALYER-CALDWELL, Tarrant County Public Health, TX JAY BUECHE, H-E-B JEANNE SHEFFIELD, University of Texas Southwestern Medical Center and the American College of Obstetricians and Gynecologists WAYNE HACHEY, Office of the Assistant Secretary of Defense (Health Affairs) Seattle MARK HORTON, California Department of Public Health DAVID FLEMING, Public Health–Seattle & King County, WA JENNIFER ARNOLD, Washington State Pharmacy Association NEIL KANESHIRO, Woodinville Pediatrics, WA, and the Washington State Chapter of the American Academy of Pediatrics J. MICHAEL MUHM, The Boeing Company LEONARDO PEREIRA, Oregon Health and Science University Discussion with Panelists and Attendees SESSION II: PROGRAM IMPLEMENTATION AND VACCINE ADMINISTRATION Session Objectives • Examine how jurisdictions and providers interpreted and applied the CDC/ACIP guidance: o Was vaccine administered sequentially or simultaneously to groups within the target population? o Was vaccine restricted to subgroups within the target population? o Was vaccine administered to groups outside the target population? If so, how and why was that decision made? o How was demand among target populations assessed? o What criteria were used for expanding beyond initial target populations? o What challenges arose in the interpretation, implementation, and regional coordination of CDC/ACIP recommendations

OCR for page 103
APPENDIX B 107 for H1N1 vaccination? Would a more restrictive, uniform approach have been desirable, or was the flexibility of the CDC/ACIP guidance important? o How did local interpretation of CDC/ACIP guidance influence strategy for vaccine administration? • Discuss lessons learned and how challenges might be addressed to help improve future emergency vaccination programs and other medical countermeasure campaigns. Overview and Panel Objectives Raleigh, Austin DAVID LAKEY, Panel Chair, Texas Department of State Health Services Seattle JEFFREY DUCHIN, Panel Chair, Public Health–Seattle & King County, WA Panel Remarks Raleigh LAUREN SMITH, Massachusetts Department of Public Health RAHUL GUPTA, Kanawha–Charleston Health Department, WV BEVERLY PRITCHETT, Washington, DC, Department of Health SCOTT NEEDLE, Collier Health Services, Inc., FL, and the American Academy of Pediatrics CAROL CUNNINGHAM, Ohio Department of Public Safety JOHN CARSON ROUNDS, Village Family Care, NC, and the American Academy of Family Physicians Austin JULIE MORITA, Chicago Department of Public Health, IL PERRY BYNUM, Haltom City Fire/Rescue, TX STEPHEN BLAIR, American Academy of Family Physicians JASON TERK, Cook Children’s Physician Network, TX, and the Texas Pediatrics Society TOM SHIMABUKURO, Centers for Disease Control and Prevention Seattle TERESA GARRETT, Utah Department of Health KRISTEN EHRESMANN, Minnesota Department of Health JOE FINKBONNER, Northwest Portland Area Indian Health Board

OCR for page 103
108 THE 2009 H1N1 INFLUENZA VACCINATION CAMPAIGN ALONZO PLOUGH, County of Los Angeles Department of Public Health, CA DAVID GROSSMAN, Group Health Cooperative, WA Discussion with Panelists and Attendees SESSION III: COMMUNICATION STRATEGIES Session Objectives • Provide an overview of strategies used by communities to inform the general public, vulnerable populations, select target populations, and priority workforce (e.g., healthcare providers and first responders) about the threat of the pandemic and the availability of and eligibility for vaccine: o What strategies were successful and unsuccessful in developing and delivering communication messages for specific segments of the population? o What particular challenges were associated with different population groups? o Given the challenges of vaccine availability, what strategies were used to manage expectations of providers, target populations, and the public? o How were target populations informed about vaccine availability? o How were target populations assured about vaccine safety? • Discuss lessons learned and how challenges might be addressed to help improve future emergency vaccination programs and other medical countermeasure campaigns. Overview and Panel Objectives Raleigh, Seattle JACK HERRMANN, Panel Chair, National Association of County and City Health Officials Austin KRISTINE SHEEDY, Panel Chair, Centers for Disease Control and Prevention

OCR for page 103
APPENDIX B 109 Panel Remarks Raleigh KARYL RATTAY, Delaware Department of Health and Social Services PAMELA BLACKWELL, Cobb & Douglas Public Health, GA DAVID BROWN, The Washington Post BENJAMIN RACKLEY, Tuskegee Area Health Education Center, Inc., AL JULIE HENRY, North Carolina Department of Health and Human Services Austin PAUL HALVERSON, Arkansas Department of Health LESLEA BENNETT-WEBB, Oklahoma State Department of Health CANDACE CRAUSE, Champaign-Urbana Public Health District, IL GREG BOGDAN, Rocky Mountain Poison & Drug Center at Denver Health, CO MAGGIE FOX, Reuters Seattle SELENA MANYCHILDREN, Navajo Division of Health MOHAMED SHEIKH HASSAN, Afrique Service Center, WA TIFFANY SUTTER, California Department of Public Health GREG WILKINSON, State of Alaska Health and Social Services Discussion with Panelists and Attendees SESSION IV: MONITORING, IMPACT, AND EVALUATION Session Objectives • Examine and discuss strategies that were used to collect, monitor, evaluate, and use data during the H1N1 vaccination campaign: o What data were used to ascertain the impact and reach of this immunization effort? o What data would have been especially helpful but were not available?

OCR for page 103
110 THE 2009 H1N1 INFLUENZA VACCINATION CAMPAIGN o How can data be gathered and analyzed quickly during an event in order to drive policy immediately? o Was it possible to assess vaccine coverage? What levels of coverage were achieved among different populations, and did the H1N1 vaccination campaign adequately immunize persons in the ACIP target groups? o What data were used or would be most useful to improve immunization rates for persons in the target groups and in the general population? • Discuss lessons learned and how monitoring, impact, and evaluation can be improved for future emergency vaccination programs and other medical countermeasure campaigns. Overview and Panel Objectives Raleigh CATHY SLEMP, Panel Chair, West Virginia Department of Health and Human Resources Austin B. TILMAN JOLLY, Panel Chair, Department of Homeland Security Seattle BETH BELL, Panel Chair, Centers for Disease Control and Prevention Panel Remarks Raleigh KAREN REMLEY, Virginia Department of Health DAVID GRUBER, New Jersey Department of Health and Senior Services BETH MALDIN MORGENTHAU, New York City Department of Health and Mental Hygiene, NY LAURA WILLIAMS, Boston EMS, MA PASCALE WORTLEY, Centers for Disease Control and Prevention BETH ROWE-WEST, Association of Immunization Managers Austin DANIEL HOPFENSPERGER, Wisconsin Department of Health Services EDUARDO SANCHEZ, Blue Cross and Blue Shield of Texas ANGIE HAGY, City of Milwaukee Health Department, WI

OCR for page 103
APPENDIX B 111 PAMELA FALK, University of Texas Medical Branch at Galveston Seattle CATHY SLEMP, West Virginia Department of Health and Human Resources ANTHONY L.-T. CHEN, Tacoma–Pierce County Health Department, WA LAURENE MASCOLA, Los Angeles County Department of Public Health, CA RICHARD JUSTMAN, UnitedHealth Group Discussion with Panelists and Attendees SESSION V: GENERAL DISCUSSION WITH WORKSHOP PARTICIPANTS AND ATTENDEES Session Objectives Discuss opportunities and constraints identified during the workshop that may help inform future efforts to administer vaccine and dispense medical countermeasures. As future campaigns are developed and time- dependent scenarios considered, what improvements are needed to ensure a safe, robust, and timely response? Panel Discussion: Implementing the Lessons Learned Raleigh LISA KOONIN, Panel Chair, Centers for Disease Control and Prevention CATHY SLEMP, West Virginia Department of Health and Human Resources PAMELA BLACKWELL, Cobb & Douglas Public Health, GA SCOTT NEEDLE, Collier Health Services Inc., FL, and the American Academy of Pediatrics Austin JEFFREY DUCHIN, Panel Co-Chair, Public Health–Seattle & King County, WA LISA KOONIN, Panel Co-Chair, Centers for Disease Control and Prevention

OCR for page 103
112 THE 2009 H1N1 INFLUENZA VACCINATION CAMPAIGN TOBY MERLIN, Centers for Disease Control and Prevention DAVID LAKEY, Texas Department of State Health Services Seattle TOBY MERLIN, Panel Chair, Centers for Disease Control and Prevention JAMES BLUMENSTOCK, Association of State and Territorial Health Officials CATHY SLEMP, West Virginia Department of Health and Human Resources JACK HERRMANN, National Association of County and City Health Officials Moderated Discussion with Panelists and Attendees • What new ideas have surfaced in this meeting today that should be explored further? • Were lessons learned during the pandemic response that could enhance efforts to reduce the burden of seasonal flu in future years? • Were any examples discussed that could be implemented immediately to improve the efficiency and effectiveness of the vaccine administration system? • What further evaluation questions remain? Closing Remarks Raleigh JAY BUTLER, Workshop Co-Chair, Centers for Disease Control and Prevention Austin, Seattle JEFFREY DUCHIN, Workshop Co-Chair, Public Health–Seattle & King County, WA